Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of postoperative delirium in obstructive sleep apnea patients
ChiCTR2500108088Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative delirium (POD) (3 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: postoperative delirium. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500108088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108088.